CUREMETA
Curemeta generates therapeutic antibodies to novel cancer targets and develops new cancer drugs to provide meaningful treatments and cures for patients with aggressive and metastatic cancers.
CUREMETA
Industry:
Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.curemeta.com
Total Employee:
1+
Status:
Active
Contact:
+1 857 263 8343
Technology used in webpage:
Euro Google Apps For Business
Similar Organizations
Advaite
Advaite develops a therapeutic and diagnostic solution for cancer.
Ariagen
Ariagen is a biotech company that develops a novel class of small molecules as cancer immunotherapies.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Episteme Prognostics
Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer.
ImmunePath
ImmunePath is a biotechnology company that develops stem cell based therapeutics based in Menlo Park, California.
MetaVi Labs
MetaVì Labs is a company wholly dedicated to stopping metastasis formation.
Rosa & Co
Rosa & Co is a company that creates robust mathematical models that simulate drug effects and trial outcomes.
SixOne Solutions
First in class targeted therapy for metastatic breast cancer
Official Site Inspections
http://www.curemeta.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Curemeta"
CureMeta
Our Mission. Our mission is to generate therapeutic antibodies to novel cancer targets and develop new cancer drugs to provide meaningful treatments and cures for patients with …See details»
General 5 — CureMeta
CureMeta was founded in 2012 with the goal to discover novel targets and develop novel antibody therapeutic drugs to treat aggressive and metastatic cancers and provide real and meaningful …See details»
Curemeta - Crunchbase Company Profile & Funding
Organization. Curemeta . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Curemeta generates therapeutic antibodies to novel cancer targets and develops new cancer drugs …See details»
Curemeta Company Profile | Management and Employees List
Curemeta Profile and History CureMeta is a privately funded cancer research biotech company located in the Seaport district of Boston Massachusetts. Our research efforts at CureMeta - …See details»
General 5 — CureMeta
We have developed a proprietary antibody platform and have generated a robust pipeline of antibodies to novel cancer targets. Our lead cancer drug, CM-09 is a First-in-Class ADC to …See details»
Curemeta - Contacts, Employees, Board Members, Advisors
Curemeta is a biotech company that develops therapeutic antibodies to cure metastatic cancer.See details»
CureMeta - VentureRadar
"Our mission is to develop therapeutic antibodies to novel cancer targets that are present in aggressive cancers and to develop new powerful cancer drugs to provide meaningful …See details»
CureMeta LLC Information - RocketReach
The NAICS codes for CureMeta LLC are [541, 541713, 5417, 54, 54171]. What is the SIC code for CureMeta LLC? The SIC codes for CureMeta LLC are [87, 873]. Top CureMeta LLC …See details»
Curemeta LLC Company Profile | Boston, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Curemeta LLC of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
CureMeta LLC - Company Profile & Staff Directory - ContactOut
CureMeta is a privately funded cancer research biotech company located in the Seaport district of Boston Massachusetts. Our research efforts at CureMeta - which stands for curing metastatic …See details»
About CureMeta Original — CureMeta
About. CureMeta is a Boston-based, private company founded in 2012 with the goal to discover novel targets and develop novel antibody therapeutic drugs to treat aggressive and metastatic …See details»
Curemeta - Overview, News & Similar companies | ZoomInfo.com
CureMeta is a privately funded cancer research biotech company located in the Seaport district of Boston Massachusetts. Our research efforts at Cur eMeta - which stands for curing metastatic …See details»
Curemeta - Crunchbase
Curemeta is a biotech company that develops therapeutic antibodies to cure metastatic cancer.See details»
CUREMETA Revenue, Growth & Competitor Profile - incfact.com
Apr 1, 2024 Determine whether Curemeta grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how …See details»
Bstrongximab ADC (CureMeta) - Drug Targets, Indications, Patents …
Bstrongximab ADC (CureMeta): a TRA-1-60 inhibitors, Tubulin inhibitors, Immunomodulators Drug, Initially developed by CureMeta LLC, Now, its global highest R&D status is Pending, …See details»
General 5 — CureMeta
Since 2012, CureMeta has generated compelling preclinical research data showing TRA-1-60 is present on the cell surface of cancer cells in aggressive and metastatic tumors. Nine …See details»
Curemeta - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Curemeta uses 5 technology products and services including HTML5, Google Fonts, and Adobe Fonts, according to G2 Stack. Curemeta is actively using 15 technologies for its website, …See details»
CuriMeta Company Profile - Office Locations, Competitors ... - Craft
CuriMeta has 5 employees at their 1 location and $6 m in total funding,. See insights on CuriMeta including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
General 5 — CureMeta
Skip to ContentSee details»
CuriMeta - Crunchbase Company Profile & Funding
Aug 30, 2022 CuriMeta is a advanced real-world health data firm with a focus on life sciences. Driven by the belief that real-world health data maintained within systems of care have unique …See details»